Deploying bacteriophage combinatorial therapy to eradicate resistant Klebsiella pneumoniae UTIs: innovative and personalized phage therapy
Archives of Microbiology · 2026
DOI: 10.1007/s00203-026-04788-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Microbiology, 2026. Verfasst von Usamah Sayed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Phage Therapy, Klebsiella pneumoniae, Bacteriophages, Urinary Tract Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 167 Literaturangaben.
Abstract (Originalsprache)
Klebsiella pneumoniae (K. pneumoniae) is a WHO priority pathogen, with multidrug-resistant (MDR) and carbapenem-resistant (CRKP) strains causing severe, often untreatable urinary tract infections (UTIs). The therapeutic impasse has reignited interest in bacteriophage (phage) therapy, a precision antibacterial approach that uses viruses to selectively lyse bacterial pathogens. The potential of phage therapy for MDR K. pneumoniae UTIs is critically evaluated in this review. We summarize the underlying biological rationale, concentrating on phage-mediated lysis and biofilm disruption. We then examine the translational landscape, comparing promising preclinical and compassionate-use data with the limited outcomes from early controlled clinical trials. A key theme is the critical need for strategic frameworks to guide clinical deployment, including rational cocktail design, phage-antibiotic synergy (PAS), and personalized approaches. Lastly, we list the main issues that must be addressed to incorporate phage therapy into the clinical arsenal against these powerful infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
- Department of Pharmacology and Toxicology, College of Pharmacy, Al Farahidi University, Baghdad, Iraq. waleedk.abdulsahib@uoalfarahidi.edu.iq.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Turath University College, Baghdad, Iraq.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
- Department of Microbiology, IMS and SUM Hospital, Siksha 'O' Anusandhan, Bhubaneswar, Odisha, 751003, India.
- Department of Biotechnology, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
Zitieren
APA
Sayed, U., Abdulsahib, W. K., Mustafa, W. W., Malathi, H., Panigrahi, R., Latha, Y. S., Sharma, V., Sinha, A., & Khalikova, N. (2026). Deploying bacteriophage combinatorial therapy to eradicate resistant Klebsiella pneumoniae UTIs: innovative and personalized phage therapy. Archives of Microbiology. https://doi.org/10.1007/s00203-026-04788-8
Vancouver
Sayed U, Abdulsahib WK, Mustafa WW, Malathi H, Panigrahi R, Latha YS, et al. Deploying bacteriophage combinatorial therapy to eradicate resistant Klebsiella pneumoniae UTIs: innovative and personalized phage therapy. Archives of Microbiology. 2026. doi:10.1007/s00203-026-04788-8
BibTeX
@article{Sayed2026,
author = {Sayed, Usamah and Abdulsahib, Waleed K and Mustafa, Wael Waleed and Malathi, H and Panigrahi, Rajashree and Latha, Y Swarna and Sharma, Vipasha and Sinha, Aashna and Khalikova, Nigina},
title = {Deploying bacteriophage combinatorial therapy to eradicate resistant Klebsiella pneumoniae UTIs: innovative and personalized phage therapy},
journal = {Archives of Microbiology},
year = {2026},
doi = {10.1007/s00203-026-04788-8}
}
EUVIMED